In view of the impact of the pandemic on European healthcare systems, the European authorities published a guidance document on 20 March 2020 that provides sponsors with recommendations regarding clinical trials and the persons involved in them.

Supplementary Recommendations to EU Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic (Version 4.0) PDF, 186KB, File does not meet accessibility standards